The causes and sources of chemical toxicity and the detection and management of human toxicity.
The aim is to introduce students to the diverse discipline of toxicology. Principles and concepts are taught by focusing on the mechanisms responsible for the toxic effects of a wide variety of chemicals and environmental pollutants. Laboratory sessions will focus on the mechanism of the interaction between curcumin and paracetamol.
| Paper title | Human Toxicology |
|---|---|
| Paper code | PHAL306 |
| Subject | Pharmacology |
| EFTS | 0.15 |
| Points | 18 points |
| Teaching period | Semester 1 (On campus) |
| Domestic Tuition Fees (NZD) | $1,141.35 |
| International Tuition Fees | Tuition Fees for international students are elsewhere on this website. |
- Prerequisite
- PHAL 211
- Recommended Preparation
- PHAL 221 or PHAL 212
- Schedule C
- Science
- Notes
- PHAL212 is no longer offered. Students who passed PHAL211 in 2019 or earlier, but who haven’t passed PHAL212, should email pharmacology@otago.ac.nz to discuss their preparedness for PHAL306.
- Contact
- Teaching staff
Professor Rhonda Rosengren
Dr Greg Giles
Dr Jonathan Falconer
Dr Sarah Baird- Paper Structure
Assessment
- 3-Minutes Video (10%)
- Manuscript (pairs) (20%)
- Lab skills (3%)
- Lab summaries (pairs) (10%, consisting 2 x 5%)
- Final Exam (57%)
- Textbooks
- Students should concentrate on lecture notes.
- Graduate Attributes Emphasised
- Global perspective, Lifelong learning, Scholarship, Communication, Critical thinking,
Ethics, Environmental literacy, Information literacy, Research, Self-motivation, Teamwork.
View more information about Otago's graduate attributes. - Learning Outcomes
- To gain an understanding of key concepts in toxicology
- To understand the mechanisms of action produced by a range of different toxicants
- To develop scientific writing and research skills
- To further develop laboratory techniques
- To develop critical thinking in toxicology
- To use critical thinking and the students' own research to examine and draw conclusions regarding drug-mediated hepatotoxicity
